Digestion by lysozyme of delipidated cells of Mycobacterium smegmatis liberates a water-soluble immunoadjuvant fraction which is chemically very similar to the water-soluble adjuvant (WSA) obtained previously from purified cell walls, but which contains somewhat more non-peptidoglycan amino acids. The yield of peptidoglycan-arabinogalactan complex is about 10 times greater starting from whole cells than from cell walls. The main biological properties of this "neo-WSA" are described: it increases circulating antibodies to ovalbumin in guinea pigs, it does not produce polyarthritis in rats or induce hypersensitivity to tuberculin, it does not increase susceptibility to histamine or hyperreactivity to endotoxin, and does not produce spleen and liver hypertrophy. Analogous immunostimulant fractions have also been obtained from delipidated cells of Nocardia opaca by lysozyme treatment.
We have previously described water-soluble adjuvants (WSA) obtained by lysozyme digestion of purified mycobacterial cell walls (1, 4) . The WSA of Mycobacterium smegmatis, which was the organism most thoroughly studied, contains a peptidoglycan covalently linked to an arabinogalactan and is able to replace whole cells or cell walls of mycobacteria in Freund adjuvant (1) . It was also demonstrated that WSA, which can also increase the immune response to a viral antigen, is devoid of the toxic properties of whole mycobacterial cells. The administration of this preparation does not induce splenomegaly, hyperreactivity to endotoxin, or sensitivity to tuberculin. It was also shown that, whereas WSA administered with ovalbumin in Freund incomplete adjuvant (FIA) elicits delayed sensitivity to this antigen, it does not produce experimental polyarthritis (4) .
We have now obtained WSA by direct digestion of whole delipidated cells with lysozyme. By this procedure, more than 90% of the peptidoglycan-arabinogalactan complex of M. smegmatis is solubilized (as compared to 10% when trypsin-chymotrypsin-treated delipidated cell walls are the starting material [1] ), leading to a water-soluble immunostimulant fraction. Similar preparations could also be obtained from Nocardia opaca (A. Adam et al., Colloq. Int. Cent. Nat. Rech. Sci. 1972, in press ). These immunoadjuvant preparations, hereafter referred to as "neo-WSA," are also devoid of the above-mentioned toxic properties inherent to whole mycobacterial cells.
Since the appearance of our first publications (1, 4) (15) and identified by chromatography on Whatman no. 1 paper in ethyl acetate-pyridine-water (8:2:1).
Immunoadjuvant activity. Male Hartley guinea pigs of the Pasteur Institute strain weighing 350 g were injected in both hind footpads with 0.1 ml of a water-in-oil emulsion made of equal parts of (i) a saline solution of ovalbumin (50 mg/ml; egg albumin, 5 times crystallized, B grade, Calbiochem) and of (ii) either Freund complete adjuvant (FCA) or FIA (Difco). The mycobacterial fractions (2 mg/ml) were added to the antigen in the saline solution. The animals were sacrificed 3 weeks later, and the titers of circulating precipitins (10) and agglutinins (7) n a column of Sephadex G-75, giving the elution profile shown in Fig. 2 . Fraction A, weighing 40 mg, contained no DAP and was not investigated further. Fraction B (referred to as neo-WSA N. op.), weighing 120 mg, contained 16% neutral sugars, 18% amino sugars (muramic acid and glucosamine in equimolar proportions), 39% amino acids (half of them being Ala, Glu, and DAP), 5% lipids, and 2% phosphorus. The composition of this complex mixture is undergoing further investigation. Fraction C, weighing 140 mg, contained neutral sugars, amino sugars (muramic acid and glucosamine in equimolar proportions), amino acids (Ala, Glu, and DAP representing 60% of them), less than 5% lipid, and 5% phosphorus.
Immunoadjuvant activity of neo-WSA from M. smegmatis and N. opaca. The immunoadjuvant activity of various preparations was measured by evaluating the increase of circulating antibodies to ovalbumin. This is illustrated in Table 2 ments with groups of six guinea pigs for each preparation.
The antigen was administered in the hind footpads to the control groups with FIA. For the other groups, the antigen was administered in combination with: (i) WSA, crude or purified, extracted from the cell walls of M. smegmatis; (ii) various preparations of neo-WSA extracted from delipidated cells of M. smegmatis and, in one case, of N. opaca. All the mycobacterial fractions were used with FIA. The titers of precipitins were significantly increased in the sera of guinea pigs treated by FCA or by the various water-soluble adjuvants (Table 2) . In all groups, the agglutinins were also higher than for the FIA controls. This increase was uniformly significant except for the guinea pigs treated with FIA.
Experimental polyarthritis in the rat. In the following experiment, groups of eight rats were injected with various preparations of neo-WSA in FIA. Control animals received an injection of FIA with or without whole mycobacterial cells.
FIA administered alone produced a weight increase of the injected paws (53%) without preventing the gain of body weight (Table 3) . When FIA is administered with whole mycobacterial cells, there is a lack of body weight gain and a much greater weight increase of the injected paws (117% in the case of BCG and 141% in the case of M. smegmatis). No such changes were observed with the various preparations of neo-WSA even though the dosage level used was very high (0.5 mg). The effects produced were not meaningfully different from those obtained in the control animals by the injection of FIA alone.
Susceptibility to histamine and hyperreactivity to endotoxin. Corynebacterium or Ha- emophilus pertussis, which are also potent immunoadjuvants, sensitize mice to histamine and to passive anaphylaxis, whereas such an effect is not observed with BCG (2, 13, 16) . Nevertheless, it should be ascertained whether any new mycobacterial preparation sensitizes to histamine. Male Swiss mice were challenged by intravenous route with various doses of histamine 7 days after having been treated with 1 mg of neo-WSA in saline. In contrast to adrenalectomized or H. pertussis-treated control animals, the susceptibility to histamine was not increased by neo-WSA. It is well established that BCG, like
Corynebacterium or H. pertussis, sensitizes mice to endotoxin (9, 12, 17) , whereas WSA is devoid of this toxic effect (4). The mean lethal dose for endotoxin is 280 ug for untreated control animals, and this value is lowered to 1.5 ,gg after administration of BCG (Table 4) . In contrast, all the mice which had been treated by the various preparations of neo-WSA survived when challenged with 15 Mg of endotoxin, and only in one case were three mice out of seven killed with 50 ,ug.
It has been assumed that hyperreactivity to endotoxin is related to granuloma formation in the spleen and various other organs (9) .
Spleen and liver hypertrophy. Mice received 0.2 ml of saline intravenously with or without 300 MAg of the various mycobacterial preparations. The animals were killed 14 days later. BCG produced a significant hypertrophy of the spleen and of the liver (Table 5 ). In However, there is a striking difference in the percentage of the peptidoglycan-arabinogalactan complex obtained from cell walls and whole cells of M. smegmatis as described herein. Lysozyme solubilizes about 10% of the complex in purified cell walls and about 90% of that in delipidated whole cells. The reasons for this difference are not yet fully understood. It could be postulated that, since the delipidation of cell walls is done at room temperature and that of the whole cells in a Soxhlet extractor, the somewhat elevated temperature of the latter method breaks some linkages of the arabinogalactan mycolate, thus liberating the lipid moiety. The resulting peptidoglycan-arabinogalactan complex would then be susceptible to hydrolysis by lysozyme. Another possibility is that an esterase of the autolytic system, able to break the linkage between arabinose and mycolic acid, is removed during the preparation of the cell walls but remains intact in whole cells and acts during the incubation with lysozyme.
The chemical composition, molecular weight, and biological activities of the immunoadjuvant obtained from delipidated cells of M. smegmatis are similar to those obtained from purified cell walls. M. smegmatis, however, contains more non-peptidoglycan amino acids (Table 1 ). These may be derived from contaminating proteins or from peptide chains covalently linked to the basal structure of the cell wall and are removed when cell walls are treated with trypsin and chymotrypsin.
Freund (5) has already shown that nocardia (e.g., N. asteroides) can be used instead of mycobacteria in Freund adjuvant. We have shown here that soluble immunoadjuvants can be obtained from nocardia as well as from mycobacteria. A comparison of the detailed structure of immunoadjuvants from both genera might give some clues to the chemical nature of the minimal structures required for adjuvant activity.
The method described here allows a relatively easy large-scale preparation of WSA and makes these fractions available for extensive biological testing.
